A unique collection of xnum cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research;

A unique collection of xnum natural products for high throughput screening (HTS) and high content screening (HCS);

A collection of xnum natural product molecules originated from Tibetan medicine, which can be used for high-throughput and high-content screening.

A unique collection of xnum compounds targeting ion channels for research in ion channels-related diseases and ion channel drug discovery;

A unique collection of xnum cell cycle related compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS).

A unique collection of xnum natural polyphenolic compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum kinase inhibitors/regulators for high throughput screening and high content screening for drug discovery in kinase related diseases;

xnum compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum approved drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum stem cell differentiation signaling targeted compounds for high throughput and high content screening;

A unique collection of xnum compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A collection of xnum small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification;

A unique collection of xnum anti-obesity compounds for high throughput and high content screening;

A collection of xnum selected human endogenous metabolites for high throughput and high content screening.

A unique collection of 1729 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 500 natural alkaloids can be used for high throughput and high content screening；

A unique collection of xnum compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening；

A unique collection of xnum compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A collection of xnum bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification.

A unique collection of xnum compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs;

Well-chosen xnum compounds related to epigenetic regulation for research in epigenetics, high throughput screening (HTS) and high content screening (HCS) for new drugs;

A unique collection of xnum anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening;

A unique collection of xnum natural terpenes and terpenoids can be used for high throughput and high content screening；

A unique collection of xnum DNA Damage & Repair related compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum flavonoids can be used for high throughput and high content screening；

A unique collection of xnum metabolism diseases related compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS);

xnum methylation-related compounds that can be used for high-throughput and high-content screening.

A unique collection of xnum compounds targeting chromatin remodeling pathway for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum compounds targeting serotonin receptors for high throughput screening and high content screening;

Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species (ROS) and a biological system's ability to readily detoxify the reactive intermediates or repair the resulting damage. Disturbances in the normal redox state of cells can cause toxic effects through the production of peroxides and free radicals that damage all components of the cell, including proteins, lipids, and DNA. In humans, oxidative stress is thought to be involved in the development of atherosclerosis, heart failure, myocardial infarction, cancer, infection etc. Antioxidants are a class of compounds that counteract oxidative stress and reduce oxidative damage. The TargetMol Antioxidant Compound Library is a unique collection of xnum small molecules with inhibitory effects on oxidative stress and is a useful tool for high-throughput screening and high-content screening in the study of oxidative stress.

A unique collection of xnum compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs;

A unique collection of xnum microbial natural products for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum compounds targeting PI3K/Akt/mTOR signaling for research in PI3K/Akt/mTOR signaling, and drug discovery in diseases involved with PI3K/Akt/mTOR signaling;

A unique collection of xnum drug isomers/metabolites for high throughput screening (HTS) and high content screening (HCS);

xnum Chemotherapeutic drugs that can be used for high-throughput and high-content screening.

xnum non-steroidal anti-inflammatory compounds for high-throughput and high-content screening.

xnum tumor-targeted drugs that can be used for high-throughput and high-content screening.

xnum species of cyclic peptide molecules for high-throughput and high-content screening;

A unique collection of xnum preclinical compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum anti-inflammation compounds effective for high throughput screening and high content screening.

A unique collection of xnum toxic substances for high throughput screening (HTS) and high content screening (HCS);

xnum hypertension-related small molecules for high-throughput and high-content screening.

A unique collection of xnum proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum anticancer drugs for high throughput screening (HTS) and high content screening (HCS);